Skip to content

Publications, events, virus pictures...

Latest news

NeoVirTech SAS and VirexpR SAS create a strategical alliance to combine NeoVirTech’s autofluorescent viruses with VirexpR nebulization technologies for airborne disinfection testing.

27 février 2023 |
NeoVirTech SAS and VirexpR SAS create a strategical alliance to combine NeoVirTech’s autofluorescent viruses with VirexpR nebulization technologies for airborne disinfection testing. What if we could combine our autofluorescent viruses
READ MORE

NeoVirTech SAS and BioImmunitas Ltd enter into collaboration to advance BioImmunitas proprietary therapeutic hRP platform on the antiviral market

21 février 2023 |
NeoVirTech SAS and BioImmunitas Ltd enter into collaboration to advance BioImmunitas proprietary therapeutic hRP platform on the antiviral market NeoVirTech (NVT) and BioImmunitas Ltd enter a long-term partnership to advance
READ MORE

Picture of the month, January 2023

23 janvier 2023 |
Picture of the month, January 2023   Picture (art) of the month, January 2023. Human cells infected with VACV ANCHOR poxvirus (green: infected cells, greendots: viral DNA) and stained with
READ MORE

New article published in Nature Microbiology on the use of Tecovirimat against MPXV

8 novembre 2022 |
Tecovirimat is efficient against the 2022 MPXV strain circulating in Europe Delighted to see our work on the efficiency of Tecovirimat on the European Monkeypox virus strain published today in
READ MORE

Picture of the month, October 2022

26 octobre 2022 |
Picture of the month, October 2022 SARS-CoV-2 infecting human pulmonary cells 48h post-infection, nuclei in blue, SARS-CoV-2 RNA in green, SARS-CoV-2 NP in red. Work done by Charlotte Quentin-Froignant.
READ MORE
LOAD MORE